How the minefield that is socia media could actually prove beneficial for the world of pharma.
The Small Company That Grew
Once a minor force in the world pharmaceutical market, Nycomed became a major player following its acquisition of Altana Pharma in 2006. CEO Håkan Björklund tells Marie Shields how the company is positioned to meet the challenges of its extraordinary growth.
Winner takes all
The competition between branded drugs and generic copies has been going on for years, but as generics threaten to take the lead, how will their rivals fight back? By Marie Shields
In with the new
When Chris Viehbacher arrived to take up the reins as CEO of sanofi-aventis at the end of last year, he found a company with an image problem that had forgotten how to communicate. Now he plans to change all that, as Marie Shields finds out.
Standing out from the crowd
Mike Cola and Sylvie Gregoire of Shire Pharmaceuticals explain why being different is increasingly important in the dark days of economic recession. By Natalie Brandweiner
Riding the wave
The global pharmaceutical industry is facing some tough challenges at the moment: patent expiries, a lack of new blockbusters, and now the ongoing crisis in the financial markets. But Merck Serono’s Bernhard Kirschbaum isn’t too worried, as he tells NGP’s Marie Shields.